Search papers, labs, and topics across Lattice.
This paper introduces a conformal prediction framework specifically designed to address label shift in predicting molecular properties critical to drug development. By employing marginal label probability ratios to weight conformal scores, the method generates statistically rigorous prediction intervals without the need for retraining, thus providing robust uncertainty quantification. The results indicate that this approach significantly enhances the reliability of AI predictions in drug discovery, aligning them with regulatory standards for transparency and uncertainty reporting.
Predictive modeling in drug development can now provide actionable confidence measures, transforming how we assess molecular properties under shifting conditions.
Drug discovery and development underpins healthcare but remains costly and failure-prone. A critical bottleneck lies in predicting molecular properties such as solubility, potency, and toxicity, which directly determine whether a candidate can advance from preclinical to clinical trials. Artificial Intelligence (AI) has accelerated this process, yet its reliability is often undermined by distribution shift, as experimental conditions frequently diverge from training data. In addition, conventional point predictions provide only single-value estimates, offering limited guidance for high-stakes experimental design. We address these challenges with a conformal prediction framework tailored to label shift. By weighting conformal scores using marginal label probability ratios, our method produces statistically rigorous prediction intervals without retraining. This enables robust uncertainty quantification even when property distributions drift, directly tackling one of the most pervasive obstacles to applying AI in real-world drug development. By moving beyond accuracy alone to provide actionable confidence measures, our approach enhances the trustworthiness of AI-driven predictions. This further aligns predictive modeling with regulatory demands for transparency and uncertainty reporting and ultimately supports more reliable decision-making in billion-dollar development pipelines.
